Richard J. Beninger – författare

Since its discovery in the 1960s, a vast and wide-ranging body of research has accumulated about the dopaminergic system. Life's Rewards: Linking Dopamine, Incentive Learning, Schizophrenia, and the Mind offers a broad synthesis of our current understanding of this chemical, addressing, amongst others, its intricate relationship with learning and memory, psychopathology, social co-operation, and drug abuse.Aimed at students and researchers in neuroscience and psychology, Life's Rewards: Linking Dopamine, Incentive Learning, Schizophrenia, and the Mind is essential reading for anyone interested in the relationship between dopamine and reward-related incentive learning.

Book chapters are authored by participants in the International Meeting on Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment, held in Mojácar (Almería) Spain from 14-18 October 2009. Chapters are organized into four sections on themes encompassed by Staging Neuropsychiatric Disorders: 1) Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders, 2) Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry, 3) Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders, and 4) Staging Neurodegenerative Disorders. This volume should serve as a resource for physicians and neuroscientists alike, highlighting the importance of staging neuropsychiatric disorders and the underlying mechanistic dysfunction, for prevention and treatment strategies at different stages of disease progression.

Book chapters are authored by participants in the International Meeting on Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment, held in Mojácar (Almería) Spain from 14-18 October 2009. Chapters are organized into four sections on themes encompassed by Staging Neuropsychiatric Disorders: Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders, Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry, Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders, and Staging Neurodegenerative Disorders. This volume should serve as a resource for physicians and neuroscientists alike, highlighting the importance of staging neuropsychiatric disorders and the underlying mechanistic dysfunction, for prevention and treatment strategies at different stages of disease progression. Earlier volumes in the series, published by the Fundación Cerebro y Mente in Madrid, Spain:Depressive, Anxiety and Drug Abuse DisordersEds: T. Palomo and T. ArcherSchizophrenia, Movement Disorders and Age Related Cognitive DisordersEds.: T. Palomo, T. Archer and R.J. BeningerDopamine Disease StatesEds.: R.J. Beninger, T. Palomo and T. ArcherInteractive Monoaminergic DisordersEds.: T. Palomo, R.J. Beninger and T. ArcherNeurodegenerative Brain DisordersEds.: T. Palomo, R.J. Beninger and T. ArcherNeurodevelopmental Liabilities in Brain Disease StatesEds.: R.J. Beninger, T. Palomo, R.M. Kostrzewa and T. ArcherGene-Environment Interplay in Brain Disease StatesEds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. ArcherImplications of CoMorbidity for Etiology and Treatment of Neuropsychiatric DisordersEds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. ArcherBeyond Neuropsychiatric Diagnostics: Symptoms not DisordersEds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer

Book chapters are authored by participants in the International Meeting on Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment, held in Mojácar (Almería) Spain from 14-18 October 2009. Chapters are organized into four sections on themes encompassed by Staging Neuropsychiatric Disorders: Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders, Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry, Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders, and Staging Neurodegenerative Disorders. This volume should serve as a resource for physicians and neuroscientists alike, highlighting the importance of staging neuropsychiatric disorders and the underlying mechanistic dysfunction, for prevention and treatment strategies at different stages of disease progression. Earlier volumes in the series, published by the Fundación Cerebro y Mente in Madrid, Spain:Depressive, Anxiety and Drug Abuse DisordersEds: T. Palomo and T. ArcherSchizophrenia, Movement Disorders and Age Related Cognitive DisordersEds.: T. Palomo, T. Archer and R.J. BeningerDopamine Disease StatesEds.: R.J. Beninger, T. Palomo and T. ArcherInteractive Monoaminergic DisordersEds.: T. Palomo, R.J. Beninger and T. ArcherNeurodegenerative Brain DisordersEds.: T. Palomo, R.J. Beninger and T. ArcherNeurodevelopmental Liabilities in Brain Disease StatesEds.: R.J. Beninger, T. Palomo, R.M. Kostrzewa and T. ArcherGene-Environment Interplay in Brain Disease StatesEds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. ArcherImplications of CoMorbidity for Etiology and Treatment of Neuropsychiatric DisordersEds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. ArcherBeyond Neuropsychiatric Diagnostics: Symptoms not DisordersEds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer